Literature DB >> 17351940

Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.

Noriko Kato1, Michiko Toukairin, Izumi Asanuma, Teiichi Motoyama.   

Abstract

Recent microarray studies have shown that the expression of hepatocyte nuclear factor-1beta (HNF-1beta) was significantly up-regulated in clear cell carcinoma (CCC) of the ovary. HNF-1beta may be a useful marker for CCC in peritoneal fluid cytology. We designed an experimental study using three CCC cell lines to evaluate the influence of alcohol fixation or air drying on immunocytochemistry for HNF-1beta. Each cell line was cultured on chamber slides or transplanted into the abdominal cavity of nude mice, then the slides or ascites smears of nude mice were immunostained with or without microwave-mediated epitope retrieval. Immunoreactivity with HNF-1beta, which was either alcohol-fixed or air-dried, was noticeably improved after microwave heating. In contrast, two serous adenocarcinoma cell lines never showed immunoreactivity. Based on these results, 21 archival Papanicolaou-stained slides of peritoneal fluid (5 CCCs, 12 serous, 2 mucinous, and 2 endometrioid adenocarcinomas) were decolorized and immunostained under heating pretreatment. Five of 5 CCCs were distinctively positive for HNF-1beta, whereas all non-CCC ovarian cancers were negative for this protein. The present study clearly demonstrated that heating epitope retrieval improved the immunoreactivity for a nuclear protein in alcohol-fixed or air-dried cytology specimens. HNF-1beta is likely to be helpful for the diagnosis of CCC in the peritoneal fluid. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351940     DOI: 10.1002/dc.20623

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  7 in total

1.  Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma.

Authors:  Hiroshi Kobayashi; Hitomi Sugimoto; Shunsuke Onishi; Kazutoshi Nakano
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

2.  Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).

Authors:  Yasuhito Tanase; Yoshihiko Yamada; Hiroshi Shigetomi; Hirotaka Kajihara; Akira Oonogi; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Exp Ther Med       Date:  2011-10-24       Impact factor: 2.447

3.  Structural basis of disease-causing mutations in hepatocyte nuclear factor 1beta.

Authors:  Peng Lu; Geun Bae Rha; Young-In Chi
Journal:  Biochemistry       Date:  2007-10-09       Impact factor: 3.162

4.  Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary.

Authors:  Noriko Kato; Gen Tamura; Teiichi Motoyama
Journal:  Virchows Arch       Date:  2007-12-08       Impact factor: 4.064

5.  Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.

Authors:  Peng Liu; Ashwani Khurana; Ramandeep Rattan; Xiaoping He; Steve Kalloger; Sean Dowdy; Blake Gilks; Viji Shridhar
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

6.  Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.

Authors:  Donavon Hiss
Journal:  J Oncol       Date:  2012-02-06       Impact factor: 4.375

7.  Structural and calorimetric studies demonstrate that the hepatocyte nuclear factor 1β (HNF1β) transcription factor is imported into the nucleus via a monopartite NLS sequence.

Authors:  Mareike M Wiedmann; Shintaro Aibara; David R Spring; Murray Stewart; James D Brenton
Journal:  J Struct Biol       Date:  2016-06-21       Impact factor: 2.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.